Refine year of publication

Refine use


There are 291 result(s) found based on the search criteria

There are no filters selected. You can refine your search using the filters on the left menu.

1-10 from 291 results
  • New Regulation on clinical trials

    28 May 2014

    On the 27th of May a new Regulation on clinical trials was published in the European Official Journal. This new Regulation will replace the national legislation on clinical studies with medicinal products. In Belgium, this is described in the Law on experiments on the human person.

    read more
  • 13/12/13: deadline for the submission of dossiers for marketing authorisations

    20 November 2013

    As the FAMHP will be closed between Christmas and New Year, we advise you to foresee December 13, 2013 as the final date for submitting requests for new marketing authorisations, variations, renewals and requests for parallel importation for medicines for human use or veterinary use. The validation of dossiers submitted after this date will only start on January 3, 2014.

    read more
  • Electronic submission of dossiers concerning marketing authorizations via CESP: update

    18 October 2013

    The FAMHP has updated the list of dossier types for which it wishes to receive your submission via the «Common European Submission Platform » (CESP)

    read more
  • Electronic submissions for marketing applications for human medicinal products: new version of the checker

    30 August 2013

    From the 1st September 2013 the new NeeS validation criteria (v4.0) need to be used regarding the technical validation of marketing applications for human medicinal products. The NeeS checker v4.0 (September 2013 release) is therefore adapted.

    read more
  • Narcotics used for the treatment of pain: a new version of the document on the size and type of packaging

    29 July 2013

    The strategy document of famhp aimed at limitingb the sizes and types of packaging of narcotic medicines used for the treatment of pain, available in pharmacies open to the public, has been updated. Version 4.3 is now available.

    read more
  • All codeine-containing medicines (or codeine derivatives) subject to medical prescription

    26 July 2013

    For the entry into force of the Royal Decree (RD) of 17th June 2013 all medicines containing codeine or codeine derivatives (dihydrocodeine, ethylmorphine, thebacon), whether pharmaceutical products or magistral and officinal preparations, can only be delivered on prescription.

    read more
  • Antitussives and decongestants: judgement of the Council of State

    22 July 2013

    In its judgments of 4th July 2013 the Council of State cancelled the decisions of 21st December 2011 of famhp leading to the modification of the marketing authorizations (MA) of antitussives and decongestants held by Medgenix, Qualiphar and Novartis.

    read more
  • Pharmacovigilance: new circulars

    19 July 2013

    Following the publication in the Belgian Official Journal of the Royal Decree of 28th May 2013 amending the Royal Decree of 14th December 2006 on medicinal products for human and veterinary use, the famhp wrote three circulars on the new legislation about pharmacovigilance. Circular 599 concerns their practical application. Circulars 600 and 601 specify the new requirements concerning the local persons responsible for pharmacovigilance for medicinal products for human use and for medicinal products for veterinary use respectively.

    read more
  • Intravenously administered iron-containing medicines: new recommendations

    17 July 2013

    The Committee for Medicinal Products for Human Use of the European Medicines Agency has reassessed the benefit / risk balance of injectable iron-containing medicines for intravenous administration. This Committee believes that their benefits outweigh their risks provided that adequate measures are taken to minimize the occurrence of allergic reactions.

    read more
  • Good distribution practices: new guidelines

    16 July 2013

    The new guidelines on good distribution practices come into force on 8th September 2013. They must be implemented by the distribution authorization holders and by the manufacturing authorization holders that operate distribution activities. In order to prepare a "FAQ" (Frequently Asked Questions) document the famhp asks all those concerned to send any questions about it before 31st August 2013.

    read more
1-10 from 291 results

Cette section présente les différentes nouvelles émises par l'AFMPS...

Last updated on 22 January 2013

5-year celebrations at famhp!

On this occasion the famhp has adopted a new visual identity and a new logo.

read more

of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)


Subscribe to our newsletter

Your e-mail